← FDA Drug Approvals (Drugs@FDA)

CHLOROTHIAZIDE W/ RESERPINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: WATSON LABS · Approved 1983-07-06

Drug application

FDA Application #

ANDA084853

Application type

Abbreviated New Drug Application (Generic)

Brand name

CHLOROTHIAZIDE W/ RESERPINE

Generic name

Chlorothiazide

Active ingredients

CHLOROTHIAZIDE; RESERPINE

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

WATSON LABS

First approval

1983-07-06

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown